- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 14.18M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $73.24K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $173.15K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $4.94M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $6.7M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.94M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $6.7M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $6.78M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $9.41M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $18.78M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $21.42M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 2.14M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$1.76M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $9.94M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $12.37M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$5.14 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$5.14 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.07M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.2M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$9.8M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.78M |